Literature DB >> 22512372

Optical quality for keratoconic eyes with conventional RGP lens and simulated, customised contact lens corrections: a comparison.

Amit Jinabhai1, W Neil Charman, Clare O'Donnell, Hema Radhakrishnan.   

Abstract

PURPOSE: To compare monochromatic aberrations of keratoconic eyes when uncorrected, corrected with spherically-powered RGP (rigid gas-permeable) contact lenses and corrected using simulations of customised soft contact lenses for different magnitudes of rotation (up to 15°) and translation (up to 1mm) from their ideal position.
METHODS: The ocular aberrations of examples of mild, moderate and severe keratoconic eyes were measured when uncorrected and when wearing their habitual RGP lenses. Residual aberrations and point-spread functions of each eye were simulated using an ideal, customised soft contact lens (designed to neutralise higher-order aberrations, HOA) were calculated as a function of the angle of rotation of the lens from its ideal orientation, and its horizontal and vertical translation.
RESULTS: In agreement with the results of other authors, the RGP lenses markedly reduced both lower-order aberrations and HOA for all three patients. When compared with the RGP lens corrections, the customised lens simulations only provided optical improvements if their movements were constrained within limits which appear to be difficult to achieve with current technologies.
CONCLUSIONS: At the present time, customised contact lens corrections appear likely to offer, at best, only minor optical improvements over RGP lenses for patients with keratoconus. If made in soft materials, however, these lenses may be preferred by patients in term of comfort. Ophthalmic & Physiological Optics
© 2012 The College of Optometrists.

Entities:  

Mesh:

Year:  2012        PMID: 22512372     DOI: 10.1111/j.1475-1313.2012.00904.x

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  8 in total

1.  Optimizing wavefront-guided corrections for highly aberrated eyes in the presence of registration uncertainty.

Authors:  Yue Shi; Hope M Queener; Jason D Marsack; Ayeswarya Ravikumar; Harold E Bedell; Raymond A Applegate
Journal:  J Vis       Date:  2013-06-11       Impact factor: 2.240

Review 2.  [Keratoconus lenses: the small correction miracle].

Authors:  U Klühspies; A Grunder; S Goebels; F Schirra; B Seitz
Journal:  Ophthalmologe       Date:  2013-09       Impact factor: 1.059

3.  Comparison of Wavefront-guided and Best Conventional Scleral Lenses after Habituation in Eyes with Corneal Ectasia.

Authors:  Gareth D Hastings; Raymond A Applegate; Lan Chi Nguyen; Matthew J Kauffman; Roxana T Hemmati; Jason D Marsack
Journal:  Optom Vis Sci       Date:  2019-04       Impact factor: 1.973

4.  Influence of rigid lens decentration and rotation on visual image quality in normal and keratoconic eyes.

Authors:  Jos J Rozema; Gareth D Hastings; Marta Jiménez-García; Carina Koppen; Raymond A Applegate
Journal:  Ophthalmic Physiol Opt       Date:  2022-09-16       Impact factor: 3.992

5.  Wavefront-guided scleral lens correction in keratoconus.

Authors:  Jason D Marsack; Ayeswarya Ravikumar; Chi Nguyen; Anita Ticak; Darren E Koenig; James D Elswick; Raymond A Applegate
Journal:  Optom Vis Sci       Date:  2014-10       Impact factor: 1.973

Review 6.  Nonsurgical Procedures for Keratoconus Management.

Authors:  L Rico-Del-Viejo; M Garcia-Montero; J L Hernández-Verdejo; S García-Lázaro; F J Gómez-Sanz; A Lorente-Velázquez
Journal:  J Ophthalmol       Date:  2017-12-21       Impact factor: 1.909

7.  A model of visual limitation in patients with keratoconus.

Authors:  Antonio Pérez-Rueda; Gracia Castro-Luna
Journal:  Sci Rep       Date:  2020-11-09       Impact factor: 4.379

8.  Assessment of Visual Quality in Eyes with Forme Fruste Keratoconus and Mild and Moderate Keratoconus Based on Optical Quality Analysis System II Parameters.

Authors:  Zhonghao Ren; Liyan Xu; Qi Fan; Kaili Yang; Shengwei Ren; Dongqing Zhao
Journal:  J Ophthalmol       Date:  2020-02-29       Impact factor: 1.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.